[Complement system regulation and C3 glomerulopathy]
1Department of Pediatrics, Peking University First Hospital, Beijing 100034, China. huijiexiao2@hotmail.com
Insights
Excessive complement system activation, particularly the alternative pathway, is implicated in glomerulonephritis. C3 glomerulopathy, marked by C3 deposition, may be treated by inhibiting this overactive complement pathway.
Area of Science:
- Immunology
- Nephrology
Context:
- The complement system is crucial for immune surveillance and maintaining bodily balance.
- Dysregulation of the complement system, especially the alternative pathway, is increasingly linked to glomerulonephritis pathogenesis.
- C3 glomerulopathy is a distinct kidney disease defined by substantial C3 deposition in glomeruli without significant immunoglobulin presence.
Purpose:
- To explore the role of complement system dysregulation in C3 glomerulopathy.
- To highlight the diagnostic features and variable clinical spectrum of C3 glomerulopathy.
- To identify potential therapeutic targets for C3 glomerulopathy.
Summary:
- C3 glomerulopathy is characterized by significant C3 deposition in the glomeruli, often with reduced plasma C3 and Factor H levels.
- This condition indicates a failure in the normal regulation of the complement system's alternative pathway.
- Clinical presentations, treatment responses, and prognoses for C3 glomerulopathy are highly variable.
Impact:
- Understanding the role of complement activation is key to diagnosing and managing C3 glomerulopathy.
- Targeting excessive complement activation presents a promising therapeutic strategy for C3 glomerulopathy.
- This research contributes to the evolving understanding of complement-mediated kidney diseases.
Abstract:
Complement system is a key system for immune surveillance and homeostasis. Excessive activation of complement system,especially the activation of alternative pathway may play a very important role in the pathogenesis of primary and secondary glomerulonephritis. C3 glomerulopathy is a newly named disease characterized by evident C3 deposition in the glomeruli with little or no immunoglobulin under immunofluorescence (IF). Its clinical and pathological manifestations vary a lot. The decreased plasma C3 and Factor H(FH)suggest that abnormal regulation of complement system plays an importment role in its pathogenesis. C3 glomerulopathy varies a lot as to its clinical manifestation, treatment and prognosis. The inhibition of excessive complement activation might be the key to treating C3 glomerulopathy.
Related Concept Videos
Complement System
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Nephrotic Syndrome I : Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
Chronic Kidney Disease III: Interprofessional Care


